|
Drug
|
Species
|
N° of patients
|
Tumor Type
|
Response
|
References
|
|---|
|
B
|
Cats
|
12
|
STS
|
SD 7 months
|
18
|
|
B
|
Dogs and cats
|
16
|
Various
|
80% CR+PR
|
19
|
|
CDDP
|
Dogs and cats
|
7
|
Various
|
84% CR
|
23
|
|
B
|
Dogs and cats
|
5
|
Various
|
CR > 24 mo
|
25
|
|
B
|
Cats
|
58
|
STS
|
Median time to recurrence: 12–19 mo
|
26
|
|
B
|
Dogs
|
22
|
STS
|
Median time to recurrence 24 mo
|
27
|
|
B
|
Dogs
|
28
|
MCT
|
82%CR > 22 mo
|
28
|
|
B
|
Cats
|
9
|
SCC
|
78%CR> 3 mo
|
29
|
|
B
|
Cats
|
1
|
Ganglioneuroblastoma
|
CR > 15 mo
|
30
|
|
B
|
Dogs
|
10
|
Melanoma
|
70% CR> 6 mo
|
34
|
|
CDDP
|
Dogs
|
1
|
Anal Melanoma
|
PR 3 mo
|
35
|
|
B
|
Dogs
|
12
|
Perianal tumors
|
83% CR
|
36
|
|
B
|
Dogs and Cats
|
6
|
Lymphoma
|
100% CR 1 wk to 36 mo
|
37
|
|
B
|
Cats
|
1
|
HPC
|
CR> 12 mo
|
39
|
|
CDDP
|
Dogs
|
1
|
Anal sac carcinoma
|
CR> 18 mo
|
40
|
|
CDDP
|
Cats
|
1
|
Fibrosarcoma
|
CR 3 mo
|
41
|
|
Mitoxantrone
|
Dogs
|
1
|
Metastatic carcinoma
|
CR > 6 mo
|
43
|
- B Bleomycin; CDDP Cisplatin; CR Complete Remission; HPC Hemangiopericytoma; MCT Mast Cell Tumors; PR Partial Remission; SCC Squamous Cell Carcinoma; SD Stable Disease; STS Soft Tissue Sarcoma.
